4 June 2024
Incanthera
plc
("Incanthera" the
"Company")
AQSE Webinar
Presentation
'Aquis Leading Lights: Meet
the Company of the Year 2024 Nominees'
Incanthera plc (AQSE:INC),
the company
focused on innovative technologies in dermatology and oncology, is
pleased to announce that it will be presenting at an Aquis Stock
Exchange Webinar, for Small Cap Awards 2024 Nominees.
'Meet the Leading Lights of Aquis
Exchange' Webinar will take place at 12.30
pm on 5 June 2024.
Chairman, Tim McCarthy, will be
presenting an overview of Incanthera's growth and progression from
the company's flotation onto Aquis in February 2020, to the most
recent commercial updates, leading to their Nominee as Aquis
Company of the Year 2024.
The presentation, which will not
contain any inside information, will be made available on the day
on the company's website, www.incanthera.com.
Aquis Stock Exchange makes a point
of championing entrepreneurship, investment and growth. This
webinar will provide an overview of AQSE and give investors and
advisors the chance to hear from and interact with the senior
management of the nominees for the Aquis Award.
For further information on the
event, the Nominees and to Register to see Incanthera's
presentation, please click on the link below:
https://smallcapnetwork.co.uk/event/small-cap-awards-nominees-meet-the-leading-lights-of-aquis-exchange/
RNS Reach is a non-regulatory news
service. By using this service an issuer is confirming that the
information contained in this announcement is of a non-regulatory
nature.
For further information please
contact:
Notes to Editors
About Incanthera plc
Incanthera is a specialist company
focused on innovative technologies in dermatology and
oncology. It seeks to identify and develop innovative solutions to
current clinical, commercially relevant unmet needs, utilising new
technology from leading specialists and academic institutions as
well as its in-house development team.
The Company originated from
the Institute of Cancer Therapeutics ("ICT") at
the University of Bradford. Incanthera's strategy
is to develop each candidate in its portfolio from initial
acquisition or discovery to securing its future through
commercially valuable partnerships at the earliest opportunity in
its development pathway.
For more information on the Company
please visit: www.incanthera.com
@incantheraplc